BioTime, Inc. (BTX) Reports Q2 Loss of $0.16/Share

BioTime, Inc. (NYSE: BTX) reported Q2 EPS of ($0.16), versus ($0.14) reported last year. Revenue for the quarter came in at $300.08 million, versus $362.25 million reported last year.

For earnings history and earnings-related data on BioTime, Inc. (BTX) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
• Assembly Biosciences (ASMB) Tops Q2 EPS by 53c